ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 582,75
0,59%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Exagen Inc (XGN)

  7. Exagen Inc (XGN) Actualités

XGN

Exagen (XGN)

Exagen Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:XGN
DateHeureSourceTitreSymboleSociété
12/06/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
11/06/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
14/05/202422h25AllPennyStocks.comHealthcare Shares Soar Following Major Price Target IncreaseNASDAQ:XGNExagen Inc
13/05/202415h30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XGNExagen Inc
13/05/202415h27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XGNExagen Inc
13/05/202414h00GlobeNewswire Inc.Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full YearNASDAQ:XGNExagen Inc
06/05/202422h05GlobeNewswire Inc.Exagen Announces Campaign for Lupus Awareness MonthNASDAQ:XGNExagen Inc
30/04/202422h05GlobeNewswire Inc.Exagen to Announce First Quarter 2024 Results on May 13, 2024NASDAQ:XGNExagen Inc
26/04/202414h30GlobeNewswire Inc.Exagen Inc. Announces Changes to the Board of DirectorsNASDAQ:XGNExagen Inc
18/03/202413h00GlobeNewswire Inc.Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 ResultsNASDAQ:XGNExagen Inc
18/03/202412h12IH Market NewsAnticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See UpticksNASDAQ:XGNExagen Inc
08/03/202415h00GlobeNewswire Inc.Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor ForumNASDAQ:XGNExagen Inc
07/03/202422h05GlobeNewswire Inc.Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024NASDAQ:XGNExagen Inc
14/02/202413h12Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
30/01/202422h05GlobeNewswire Inc.Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:XGNExagen Inc
07/01/202418h00GlobeNewswire Inc.Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms GuidanceNASDAQ:XGNExagen Inc
30/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XGNExagen Inc
29/11/202323h11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XGNExagen Inc
27/11/202322h05Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:XGNExagen Inc
17/11/202322h06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:XGNExagen Inc
13/11/202322h05GlobeNewswire Inc.Exagen Inc. Reports Strong Third Quarter 2023 ResultsNASDAQ:XGNExagen Inc
09/11/202322h05GlobeNewswire Inc.Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis BiomarkersNASDAQ:XGNExagen Inc
02/11/202321h05GlobeNewswire Inc.Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:XGNExagen Inc
30/10/202321h05GlobeNewswire Inc.Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023NASDAQ:XGNExagen Inc
17/10/202320h50Dow Jones NewsExagen Agrees to Pay Over $650K to Resolve Kickback AllegationsNASDAQ:XGNExagen Inc
28/09/202322h05GlobeNewswire Inc.Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual MeetingNASDAQ:XGNExagen Inc
12/09/202322h05GlobeNewswire Inc.Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:XGNExagen Inc
07/08/202314h00GlobeNewswire Inc.Exagen Inc. Reports Strong Second Quarter 2023 ResultsNASDAQ:XGNExagen Inc
26/07/202322h05GlobeNewswire Inc.Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:XGNExagen Inc
25/07/202322h05GlobeNewswire Inc.Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023NASDAQ:XGNExagen Inc
 Showing the most relevant articles for your search:NASDAQ:XGN

Dernières Valeurs Consultées

NYSE
KO
Coca Cola
NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
NYSE
DIS
Walt Disney
NYSE
MRK
Merck
EU
ACA
Credit Agricole
EU
BNP
BNP Paribas
EU
PX1
CAC 40
EU
DG
Vinci
EU
HO
Thales
EU
BEL20
Bel 20
NASDAQ
GOOGL
Alphabet
EU
EN
Bouygues
EU
VK
Vallourec
EU
SGO
Cie de SaintGobain
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés